These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31054897)

  • 61. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
    Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
    BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
    Volmar KE; Chan TY; De Marzo AM; Epstein JI
    Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HER2 Status in Molecular Subtypes of Urothelial Carcinoma of the Renal Pelvis and Ureter.
    Yorozu T; Sato S; Kimura T; Iwatani K; Onuma H; Yanagisawa T; Miki J; Egawa S; Ikegami M; Takahashi H
    Clin Genitourin Cancer; 2020 Aug; 18(4):e443-e449. PubMed ID: 31983622
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Asymptomatic woman with unilateral urothelial lesions.
    Nadel S; St Amour TE; Kyriakos M
    Urol Radiol; 1987; 9(1):57-61. PubMed ID: 3603893
    [No Abstract]   [Full Text] [Related]  

  • 65. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
    Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
    World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases.
    Mai KT; Park PC; Yazdi HM; Saltel E; Erdogan S; Stinson WA; Cagiannos I; Morash C
    Eur Urol; 2006 Nov; 50(5):1111-4. PubMed ID: 16626859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations.
    Sung MT; Zhang S; Lopez-Beltran A; Montironi R; Wang M; Davidson DD; Koch MO; Cain MP; Rink RC; Cheng L
    Histopathology; 2009 Aug; 55(2):161-73. PubMed ID: 19694823
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
    Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
    Buza N; Cohen PJ; Pei Hui ; Parkash V
    Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
    van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
    J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
    Chang A; Brimo F; Montgomery EA; Epstein JI
    Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
    Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
    Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.
    Wang G; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2018 Sep; 79():57-65. PubMed ID: 29763719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A case of urothelial tumors which occurred simultaneously in bilateral upper urinary tracts and bladder presenting with anuria].
    Uemura M; Inoue H; Nishimura K; Mizutani S; Miyoshi S; Ota H
    Hinyokika Kiyo; 2001 Apr; 47(4):269-71. PubMed ID: 11411103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasmacytoid Urothelial Carcinoma of Ureter with Retroperitoneal Metastasis: A Case Report.
    Jibril A; Stevens AC
    Am J Case Rep; 2018 Feb; 19():158-162. PubMed ID: 29434183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.